YP
BMY icon

YANKCOM Partnership’s Bristol-Myers Squibb BMY Stock Holding History

YANKCOM Partnership’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$20.1K Hold
322
– – 0.01% 245
2026
Q2 		$18.6K Hold
322
– – 0.01% 233
2026
Q1 		$19.5K Hold
322
– – 0.01% 229
2025
Q4 		$17.4K Hold
322
– – 0.01% 249
2025
Q3 		$14.5K Buy
322
+40
+14% +$1.87K 0.01% 228
2025
Q2 		$13.1K Hold
282
– – 0.01% 225
2025
Q1 		$17.2K Sell
282
-45
-14% -$2.62K 0.01% 216
2024
Q4 		$18.5K Buy
+327
New +$18.3K 0.01% 211

Other funds holding BMY

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 26.62% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $127B AUM 33.25% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

YANKCOM Partnership's BMY Position: Q3 2026 in Review

YANKCOM Partnership held its Bristol-Myers Squibb (BMY) position steady in Q3 2026 at 322 shares worth $20.1K. The position accounts for 0.01% of the portfolio, ranked #245.

YANKCOM Partnership first reported a position in BMY in Q4 2024 and has held it in 8 quarters since. 1,763 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • YANKCOM Partnership held 322 shares of Bristol-Myers Squibb worth $20.1K as of Q3 2026.
  • YANKCOM Partnership left its Bristol-Myers Squibb share count unchanged in Q3 2026.
  • Bristol-Myers Squibb made up 0.01% of YANKCOM Partnership's portfolio in Q3 2026, its #245 holding.
  • YANKCOM Partnership first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 8 quarters since.
  • 1,763 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on YANKCOM Partnership's 13F filing for Q3 2026, filed 15 Oct 2026.